Suven Life Sciences Ltd Half Yearly Results

Gross Sales

2.79

3.08

3.58

4.84

6.86

Excise Duty

0

0

0

0

0

Net Sales

2.79

3.08

3.58

4.84

6.86

Other Operating Income

0

0

0

0

0

Other Income

4.38

2.85

8.04

10.35

18.24

Total Income

7.16

5.93

11.62

15.18

25.09

Total Expenditure

133.31

86.1

86.33

81.32

58.38

PBIDT

-126.14

-80.17

-74.7

-66.13

-33.29

Interest

0

0.01

0.04

0.07

0.09

PBDT

-126.14

-80.18

-74.74

-66.2

-33.38

Depreciation

2.69

2.88

2.94

3.11

3.39

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

-1

0

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-128.83

-83.06

-77.68

-68.31

-36.77

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-128.83

-83.06

-77.68

-68.31

-36.77

Extra-ordinary Items

0

0

0

0

7.46

Adjusted Profit After Extra-ordinary item

-128.83

-83.06

-77.68

-68.31

-44.23

EPS (Unit Curr.)

-5.8

0

-3.56

0

-1.69

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

22.75

21.81

21.81

21.81

21.81

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-4,521.14

-2,602.92

-2,086.59

-1,366.32

-485.27

PBDTM(%)

-

-

-

-

-

PATM(%)

-4,617.56

-2,696.75

-2,169.83

-1,411.36

-536